tiprankstipranks
Trending News
More News >
Hannover Rueck (DE:HNR1)
XETRA:HNR1

Hannover Rueck (HNR1) AI Stock Analysis

Compare
31 Followers

Top Page

DE

Hannover Rueck

(XETRA:HNR1)

Rating:72Outperform
Price Target:
€297.00
▲(10.99%Upside)
Hannover Rueck's strong financial performance heavily influences its overall score, showcasing robust growth and stability. The valuation is reasonable, bolstered by an attractive dividend yield. However, technical analysis points to a slightly bearish trend, indicating potential short-term weakness. The lack of recent earnings call and corporate events data does not impact the score calculation.

Hannover Rueck (HNR1) vs. iShares MSCI Germany ETF (EWG)

Hannover Rueck Business Overview & Revenue Model

Company DescriptionHannover Rück SE, commonly known as Hannover Re, is one of the world's leading reinsurance companies, headquartered in Hannover, Germany. Operating in the insurance sector, Hannover Re provides a comprehensive range of reinsurance services, including property and casualty reinsurance, life and health reinsurance, and specialty lines. The company serves clients globally, offering tailored reinsurance solutions that help insurance companies manage risks and enhance their financial stability.
How the Company Makes MoneyHannover Re generates revenue primarily through the underwriting of reinsurance policies and the investment of premium income. The company's key revenue streams include premiums received for reinsurance coverage, investment income from its substantial asset portfolio, and fees for providing various risk management and advisory services. Hannover Re's earnings are influenced by its ability to accurately assess and price risk, manage claims efficiently, and achieve favorable investment returns. Significant partnerships with primary insurers and a strong global presence further bolster its revenue by expanding its client base and market reach.

Hannover Rueck Financial Statement Overview

Summary
Hannover Rueck demonstrates strong financial performance with consistent revenue growth, efficient cost management, and robust cash generation. The balance sheet is solid with low leverage and strong equity, supporting financial stability. Cash flow generation is robust, providing a positive outlook for liquidity. Minor net income fluctuations slightly dampen profitability but overall financial health is strong.
Income Statement
78
Positive
Hannover Rueck's income statement shows strong performance with a consistent increase in revenue over the TTM period, indicating a solid growth trajectory. The gross profit margin is robust at 63.09%, reflecting efficient cost management. However, the slight decline in net income compared to the previous year slightly dampens the overall profitability. Net profit margin remains healthy at 9.10%, and the EBIT and EBITDA margins are strong at 12.75% and 13.05%, respectively.
Balance Sheet
82
Very Positive
The balance sheet of Hannover Rueck is solid with a healthy equity ratio of 16.65%, suggesting a strong capital structure. The debt-to-equity ratio is low at 0.38, indicating low financial leverage and risk. Return on Equity (ROE) is impressive at 18.63%, showcasing efficient utilization of shareholder funds. The company maintains substantial cash reserves, which enhances financial stability.
Cash Flow
85
Very Positive
Hannover Rueck's cash flow statement highlights robust free cash flow generation, with a healthy free cash flow to net income ratio of 2.53, indicating strong cash generation relative to earnings. The operating cash flow to net income ratio is also strong at 2.53, reflecting effective cash conversion from operations. The consistent growth in free cash flow further supports a positive outlook for liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue24.73B26.46B25.72B24.16B26.28B23.17B
Gross Profit15.60B26.46B25.72B24.16B26.28B23.17B
EBITDA3.23B3.21B2.06B1.47B1.71B1.44B
Net Income2.25B2.33B1.82B780.80M1.23B883.07M
Balance Sheet
Total Assets72.57B72.13B65.67B62.96B82.90B71.44B
Cash, Cash Equivalents and Short-Term Investments57.40B57.39B1.05B46.65B47.59B1.28B
Total Debt4.64B4.67B4.77B5.51B4.37B3.43B
Total Liabilities59.62B59.44B54.65B53.00B70.15B59.60B
Stockholders Equity12.08B11.79B10.13B9.06B11.89B11.00B
Cash Flow
Free Cash Flow5.70B5.68B5.79B4.95B4.94B3.02B
Operating Cash Flow5.70B5.68B5.79B4.95B4.94B3.02B
Investing Cash Flow-4.74B-4.41B-4.51B-5.08B-5.26B-2.03B
Financing Cash Flow-1.10B-1.10B-1.50B44.30M277.51M-726.04M

Hannover Rueck Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price267.60
Price Trends
50DMA
274.28
Negative
100DMA
264.47
Positive
200DMA
253.39
Positive
Market Momentum
MACD
-2.56
Positive
RSI
38.02
Neutral
STOCH
17.10
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:HNR1, the sentiment is Neutral. The current price of 267.6 is below the 20-day moving average (MA) of 273.59, below the 50-day MA of 274.28, and above the 200-day MA of 253.39, indicating a neutral trend. The MACD of -2.56 indicates Positive momentum. The RSI at 38.02 is Neutral, neither overbought nor oversold. The STOCH value of 17.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DE:HNR1.

Hannover Rueck Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GBSNX
75
Outperform
£52.82M16.747.93%1.16%13.60%46.74%
72
Outperform
€32.27B14.3319.63%3.36%9.68%18.57%
67
Neutral
€71.85B12.8618.25%3.17%6.63%26.20%
62
Neutral
AU$9.98B8.0610.79%5.20%31.01%38.31%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:HNR1
Hannover Rueck
267.60
38.30
16.70%
GB:SNX
Synectics
315.00
135.90
75.88%
DE:MUV2
Munich Reinsurance
550.00
98.53
21.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 28, 2025